PCI Biotech announced the appointment of Mr. Ludovic Robin, PharmD, MBA, as Chief Business Officer (CBO). Mr. Robin will also serve as a member of PCI Biotech's executive management team. He will lead all business and corporate development activities and be a key contributor to the strategic decision making for the existing pipeline and to capture new opportunities. Over the last twenty-five years, Ludovic has held numerous international managerial positions providing leadership in the pharmaceutical industry in the areas of international research and development, business development, as well as marketing and sales.